Comments
Loading...

Docebo Analyst Ratings

DCBONASDAQ
Logo brought to you by Benzinga Data
Q1 2025 Earnings in 14 days from now on Fri May 9th, before the market open
Consensus Rating1
Buy
Highest Price Target1
$62.00
Lowest Price Target1
$41.00
Consensus Price Target1
$48.75

Docebo Analyst Ratings and Price Targets | NASDAQ:DCBO | Benzinga

Docebo Inc has a consensus price target of $48.75 based on the ratings of 8 analysts. The high is $62 issued by Craig-Hallum on November 11, 2024. The low is $41 issued by Morgan Stanley on April 16, 2025. The 3 most-recent analyst ratings were released by Morgan Stanley, Needham, and Scotiabank on April 16, 2025, April 10, 2025, and March 4, 2025, respectively. With an average price target of $42.67 between Morgan Stanley, Needham, and Scotiabank, there's an implied 32.67% upside for Docebo Inc from these most-recent analyst ratings.

Analyst Trends and Forecast
2
Nov 24
0
0
0
0
Mar
2
Apr
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
3.0
Hold
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

Morgan Stanley
Needham
Scotiabank
Craig-Hallum
CIBC

1calculated from analyst ratings

Analyst Ratings for Docebo

Buy NowGet Alert
04/16/2025Buy Now27.49%Morgan Stanley
Josh Baer64%
$43 → $41MaintainsOverweightGet Alert
04/10/2025Buy Now30.6%Needham
Ryan MacDonald58%
$42 → $42ReiteratesBuy → BuyGet Alert
03/04/2025Buy Now39.93%Scotiabank
Kevin Krishnaratne32%
$55 → $45MaintainsSector OutperformGet Alert
11/11/2024Buy Now92.79%Craig-Hallum
George Sutton63%
$58 → $62MaintainsBuyGet Alert
11/08/2024Buy Now86.57%Needham
Ryan MacDonald58%
$50 → $60MaintainsBuyGet Alert
10/24/2024Buy Now71.02%Scotiabank
Kevin Krishnaratne32%
$50 → $55MaintainsSector OutperformGet Alert
09/12/2024Buy Now55.47%Needham
Ryan MacDonald58%
$45 → $50MaintainsBuyGet Alert
06/21/2024Buy Now36.82%CIBC
Stephanie Price50%
$53 → $44MaintainsOutperformerGet Alert
06/12/2024Buy Now39.93%Needham
Ryan MacDonald58%
$45 → $45ReiteratesBuy → BuyGet Alert
06/07/2024Buy Now80.35%Craig-Hallum
George Sutton63%
→ $58Initiates → BuyGet Alert
05/16/2024Buy Now39.93%Needham
Ryan MacDonald58%
$45 → $45ReiteratesBuy → BuyGet Alert
05/14/2024Buy Now71.02%Canaccord Genuity
Robert Young35%
$65 → $55MaintainsBuyGet Alert
05/14/2024Buy Now55.47%Scotiabank
Kevin Krishnaratne32%
$65 → $50MaintainsSector OutperformGet Alert
05/13/2024Buy Now64.8%CIBC
Stephanie Price50%
$58 → $53MaintainsOutperformerGet Alert
05/13/2024Buy Now83.46%Morgan Stanley
Josh Baer64%
$65 → $59MaintainsOverweightGet Alert
05/13/2024Buy Now49.25%Goldman Sachs
Kevin Kumar52%
$55 → $48MaintainsNeutralGet Alert
05/13/2024Buy Now39.93%Needham
Ryan MacDonald58%
$63 → $45MaintainsBuyGet Alert
04/19/2024Buy Now102.11%Morgan Stanley
Josh Baer64%
$67 → $65MaintainsOverweightGet Alert
02/26/2024Buy Now71.02%Goldman Sachs
Kevin Kumar52%
$44 → $55MaintainsNeutralGet Alert
02/26/2024Buy Now102.11%Scotiabank
Kevin Krishnaratne32%
$60 → $65MaintainsSector OutperformGet Alert
02/26/2024Buy Now108.33%Morgan Stanley
Josh Baer64%
$63 → $67MaintainsOverweightGet Alert
11/14/2023Buy Now74.13%Needham
Ryan MacDonald58%
→ $56Initiates → BuyGet Alert
11/10/2023Buy Now36.82%Goldman Sachs
Kevin Kumar52%
$39 → $44MaintainsNeutralGet Alert
11/10/2023Buy Now64.8%Morgan Stanley
Josh Jennings62%
$49 → $53MaintainsOverweightGet Alert
08/18/2023Buy Now52.36%Morgan Stanley
Josh Jennings62%
$40 → $49UpgradeEqual-Weight → OverweightGet Alert
08/11/2023Buy Now24.38%Morgan Stanley
Josh Jennings62%
$37 → $40MaintainsEqual-WeightGet Alert
05/22/2023Buy Now15.05%Goldman Sachs
Kevin Kumar52%
→ $37Initiates → NeutralGet Alert
05/12/2023Buy Now15.05%Morgan Stanley
Josh Jennings62%
$39 → $37MaintainsEqual-WeightGet Alert
03/10/2023Buy Now21.27%Morgan Stanley
Josh Jennings62%
$36 → $39MaintainsEqual-WeightGet Alert
03/10/2023Buy Now55.47%Canaccord Genuity
Robert Young35%
$40 → $50MaintainsBuyGet Alert
11/11/2022Buy Now11.94%Morgan Stanley
Josh Baer64%
$40 → $36MaintainsEqual-WeightGet Alert
10/25/2022Buy Now24.38%Morgan Stanley
Josh Baer64%
$44 → $40MaintainsEqual-WeightGet Alert
08/12/2022Buy Now36.82%Morgan Stanley
Josh Baer64%
$41 → $44MaintainsEqual-WeightGet Alert
07/19/2022Buy Now27.49%Morgan Stanley
Josh Baer64%
$43 → $41MaintainsEqual-WeightGet Alert
05/13/2022Buy Now33.71%Morgan Stanley
Josh Baer64%
$54 → $43MaintainsEqual-WeightGet Alert
04/26/2022Buy Now67.91%Morgan Stanley
Josh Baer64%
→ $54Initiates → Equal-WeightGet Alert

FAQ

Q

What is the target price for Docebo (DCBO) stock?

A

The latest price target for Docebo (NASDAQ:DCBO) was reported by Morgan Stanley on April 16, 2025. The analyst firm set a price target for $41.00 expecting DCBO to rise to within 12 months (a possible 27.49% upside). 17 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Docebo (DCBO)?

A

The latest analyst rating for Docebo (NASDAQ:DCBO) was provided by Morgan Stanley, and Docebo maintained their overweight rating.

Q

When was the last upgrade for Docebo (DCBO)?

A

The last upgrade for Docebo Inc happened on August 18, 2023 when Morgan Stanley raised their price target to $49. Morgan Stanley previously had an equal-weight for Docebo Inc.

Q

When was the last downgrade for Docebo (DCBO)?

A

There is no last downgrade for Docebo.

Q

When is the next analyst rating going to be posted or updated for Docebo (DCBO)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Docebo, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Docebo was filed on April 16, 2025 so you should expect the next rating to be made available sometime around April 16, 2026.

Q

Is the Analyst Rating Docebo (DCBO) correct?

A

While ratings are subjective and will change, the latest Docebo (DCBO) rating was a maintained with a price target of $43.00 to $41.00. The current price Docebo (DCBO) is trading at is $32.16, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.